Skip to Content

Cancer-Associated Thrombosis

One in five cancer patients faces the possibility of developing a blood clot or a cancer-associated thrombosis—a leading cause of death for these patients.

With a very high probability of developing blood clots, comes a very high risk of bleeding complications. Our specialists carefully optimize the use of preventive strategies and tailor the choice of anticoagulation therapies best suited to your unique situation. In collaboration with the Kellogg Cancer Center, our Cancer-Associated Thrombosis clinic attends to the individualized needs of our patients during the entire disease trajectory.

Contributing to advances in patient care through innovative research, NorthShore is currently participating in clinical trials focused on the use of novel anticoagulants for treatment and prevention of cancer-associated thrombosis. 

For More Information

To request additional information or schedule an appointment with one of our vascular medicine specialists, please call 847.663.8050.